The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk.
atypical endometrial hyperplasia
bariatric surgery
endometrial cancer
obesity
weight loss
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
28
06
2018
revised:
21
08
2018
accepted:
19
09
2018
pubmed:
6
10
2018
medline:
23
4
2019
entrez:
6
10
2018
Statut:
ppublish
Résumé
Obesity is the strongest risk factor for endometrial cancer (EC). To inform targeted screening and prevention strategies, we assessed the impact of obesity and subsequent bariatric surgery-induced weight loss on endometrial morphology and molecular pathways implicated in endometrial carcinogenesis. Blood and endometrial tissue were obtained from women with class III-IV obesity (body mass index ≥40 and ≥50 kg/m
Identifiants
pubmed: 30289975
doi: 10.1002/ijc.31913
pmc: PMC6519061
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
641-650Subventions
Organisme : Department of Health
ID : NIHR-CS-012-009
Pays : United Kingdom
Informations de copyright
© 2018 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Curr Biomark Find. 2014 Jan 15;2014(4):1-7
pubmed: 24639918
J Clin Oncol. 2017 Apr 10;35(11):1189-1193
pubmed: 28165909
Lancet Oncol. 2009 Jul;10(7):653-62
pubmed: 19556163
Clin Cancer Res. 1998 Nov;4(11):2779-85
pubmed: 9829742
Cochrane Database Syst Rev. 2014 Dec 22;(12):ED000095
pubmed: 25549990
Diabetes Obes Metab. 2011 Dec;13(12):1063-72
pubmed: 21733057
JAMA. 2013 Dec 11;310(22):2416-25
pubmed: 24189773
J Clin Oncol. 2010 Feb 10;28(5):788-92
pubmed: 20065186
BJOG. 2016 Aug;123(9):1520
pubmed: 26969840
Br J Cancer. 2016 Feb 2;114(3):281-9
pubmed: 26794276
Hum Reprod Update. 2017 Mar 1;23(2):232-254
pubmed: 27920066
Anticancer Res. 2015 Dec;35(12):6401-9
pubmed: 26637849
Nat Rev Cancer. 2015 Aug;15(8):484-98
pubmed: 26205341
J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64
pubmed: 21960707
BJOG. 2016 Aug;123(9):1512-9
pubmed: 26630538
Eur J Cancer. 2015 Dec;51(18):2747-58
pubmed: 26597445
Am J Obstet Gynecol. 2016 Nov;215(5):598.e1-598.e8
pubmed: 27287687
Gynecol Oncol. 2014 Apr;133(1):63-6
pubmed: 24680593
Cancer. 1985 Jul 15;56(2):403-12
pubmed: 4005805
Gynecol Oncol. 2012 Apr;125(1):114-9
pubmed: 22198242
Lancet Oncol. 2009 Jul;10(7):640-1
pubmed: 19556164
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3119-30
pubmed: 21030602
J Natl Cancer Inst. 2015 Jul 01;107(9):
pubmed: 26134033
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
BJOG. 2013 Jun;120(7):791-4
pubmed: 23659328
Gynecol Oncol. 2010 Apr;117(1):96-102
pubmed: 20074784
Contemp Clin Trials. 2014 Sep;39(1):14-21
pubmed: 24999075
Cancer Res. 2006 Jun 1;66(11):5613-7
pubmed: 16740697
Eur J Cancer. 2008 Aug;44(12):1632-44
pubmed: 18514507
BJOG. 2013 Jun;120(7):795-800
pubmed: 23231632
Gynecol Oncol. 2015 Aug;138(2):238-45
pubmed: 26013696
Obstet Gynecol. 2013 Jun;121(6):1165-1171
pubmed: 23812448
Clin Cancer Res. 2001 Apr;7(4):892-5
pubmed: 11309338
Surg Obes Relat Dis. 2015 May-Jun;11(3):653-8
pubmed: 25820079
Br J Cancer. 2008 Jan 15;98(1):45-53
pubmed: 18026193
Obesity (Silver Spring). 2009 Apr;17(4):796-802
pubmed: 19148123
Am J Obstet Gynecol. 2011 Apr;204(4):355.e1-7
pubmed: 21324431
Hum Reprod. 2013 May;28(5):1231-6
pubmed: 23466671
Gynecol Oncol. 2012 May;125(2):477-82
pubmed: 22245711
BJOG. 2017 Sep;124(10):1584
pubmed: 28128539
J Clin Oncol. 1999 May;17(5):1382-90
pubmed: 10334522
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Lancet Oncol. 2015 Jan;16(1):36-46
pubmed: 25467404
Mod Pathol. 2017 Mar;30(3):459-468
pubmed: 27910946
Geburtshilfe Frauenheilkd. 2015 Feb;75(2):135-136
pubmed: 25797956